Suppr超能文献

使用摇头丸后的焦虑相关症状——一个案例研究。

Anxiety-related Symptoms following the Sporadic Use of Ecstasy - A Case Study.

机构信息

Department of Psychiatry and Neurosciences, Berlin Institute of Health, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Campus Charité Mitte, Berlin, Germany.

Research Group Psychotropic Substances, Psychiatric University Clinic at Hospital St. Hedwig, Charité Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.

出版信息

J Psychoactive Drugs. 2022 Sep-Oct;54(4):378-385. doi: 10.1080/02791072.2021.2006372. Epub 2021 Nov 25.

Abstract

3,4-methylenedioxymethamphetamine (MDMA/"ecstasy") is widespread in the electronic club scene, but MDMA has also been suggested for the treatment of anxiety spectrum disorders like posttraumatic stress disorder (PTSD) and social anxiety in autistic adults. Here, we report a case of a high functioning 24-old student with a sporadic recreational use of ecstasy, and a history of a single episode of obsessive-compulsive disorder (OCD). A few days after using ecstasy during a period of stressful life events, he developed a complex depersonalization/derealization syndrome (DDS) including intermittent distortions of time and very short intermittent episodes of misidentification of persons. Furthermore, obsessive thoughts reappeared and he suffered a panic attack for the first time in his life. Under combined pharmacological treatment and psychotherapy, symptoms gradually subsided until full remission after 14 months. Some months after discontinuation of escitalopram, however, panic attacks recurred, evolving into a regular pattern. Even if MDMA is a promising tool for the treatment of some anxiety spectrum disorders in the framework of substance-assisted psychotherapy, the use of ecstasy might be also harmful for some patients with a history of anxiety or dissociative symptoms, when used recreationally or as a self-medication outside of a controlled clinical setting.

摘要

3,4-亚甲二氧基甲基苯丙胺(MDMA/"摇头丸")在电子俱乐部场景中广泛存在,但也有人提出将 MDMA 用于治疗焦虑症谱系障碍,如创伤后应激障碍(PTSD)和自闭症成人的社交焦虑症。在这里,我们报告了一例高功能 24 岁学生,他偶尔使用摇头丸,有一次强迫症(OCD)发作的病史。在经历一段有压力的生活事件期间使用摇头丸几天后,他出现了复杂的人格解体/现实解体综合征(DDS),包括间歇性时间扭曲和非常短暂的间歇性身份识别错误。此外,强迫性思维再次出现,他一生中第一次出现惊恐发作。经过联合药物治疗和心理治疗,症状逐渐缓解,14 个月后完全缓解。然而,停用依他普仑几个月后,惊恐发作再次发作,形成了一种规律。尽管 MDMA 作为物质辅助心理治疗框架内治疗某些焦虑症谱系障碍的一种有前途的工具,但对于有焦虑或分离症状病史的患者,摇头丸的使用可能也有危害,无论是在娱乐场所还是在不受控制的临床环境之外进行自我用药。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验